Skip to main content
SpringerLink
Log in

Pharmacologie des agents de la sédation et de l’analgésie en réanimation

  • Chapter
Analgésie et sédation en réanimation

Part of the book series: Le point sur ... ((POINT))

  • 541 Accesses

Resume

La sédation-analgésie en réanimation fait appel à différents moyens médicamenteux ou non. Les moyens médicamenteux correspondent aux agents déjà utilisés en anesthésie et reposent sur l’association classique d’un hypnotique et d’un morphinique.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Soliman HM, Melot C, Vincent JL (2001) Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth 87: 186–92

    Article  CAS  PubMed  Google Scholar 

  2. Sédation, analgésie et curarisation en réanimation. Recommandations pour la pratique clinique (2000) Ann Fr Anesth Réanim 19: fi98–105

    Google Scholar 

  3. Sauder P, Andreoletti M, Cambonie G et al. (2008) Sédation-analgésie en réanimation (nouveau-né exclu). Ann Fr Anesth Réanim 27: 541–51

    CAS  PubMed  Google Scholar 

  4. Sztark F, Lagneau F. (2008) Médicaments de la sédation et de l’analgésie. Ann Fr Anesth Réanim 27: 560–6

    CAS  PubMed  Google Scholar 

  5. Payen JF, Chanques G, Mantz J et al. (2007) Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 106: 687–95

    Article  PubMed  Google Scholar 

  6. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ (2002) Sedation in the intensive care unit: a systematic review. Jama 283: 1451–9

    Article  Google Scholar 

  7. Walder B, Elia N, Henzi I et al. (2001) A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: a qualitative and quantitative systematic review. Anesth Analg 92: 975–83

    Article  CAS  PubMed  Google Scholar 

  8. Hall RI, Sandham D, Cardinal P et al. (2001) Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 119: 1151–9

    Article  CAS  PubMed  Google Scholar 

  9. Kress J, Pohlman A, O’Connor M, Hall J (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342: 1471–7

    Article  CAS  PubMed  Google Scholar 

  10. Barr J, Egan TD, Sandoval NF et al. (2001) Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 95: 324–33

    Article  CAS  PubMed  Google Scholar 

  11. Barr J, Zomorodi K, Bertaccini EJ et al. (2001) A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 95: 286–98

    Article  CAS  PubMed  Google Scholar 

  12. McMurray TJ, Johnston JR, Milligan KR et al. (2004) Propofol sedation using Diprifusor target-controlled infusion in adult intensive care unit patients. Anaesthesia 59: 636–41

    Article  CAS  PubMed  Google Scholar 

  13. Guillou N, Tanguy M, Seguin P et al. (2003) The effects of small-dose ketamine on morphine consumption in surgical intensive care unit patients after major abdominal surgery. Anesth Analg 97: 843–7

    Article  CAS  PubMed  Google Scholar 

  14. Pun BT, Ely EW (2007) The importance of diagnosing and managing ICU delirium. Chest 132: 624–36

    Article  PubMed  Google Scholar 

  15. Corbett SM, Rebuck JA, Greene CM et al. (2005) Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med 33: 940–5

    Article  CAS  PubMed  Google Scholar 

  16. Shehabi Y, Ruettimann U, Adamson H et al. (2004) Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med 30: 2188–96

    Article  PubMed  Google Scholar 

  17. Venn M, Newman J, Grounds M (2003) A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 29: 201–7

    CAS  PubMed  Google Scholar 

  18. Szumita PM, Baroletti SA, Anger KE, Wechsler ME (2007) Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm 64: 37–44

    Article  CAS  PubMed  Google Scholar 

  19. Sackey PV, Martling CR, Radell PJ (2005) Three cases of PICU sedation with isofurane delivered by the AnaConDa’. Paediatr Anaesth 15: 879–85

    Article  PubMed  Google Scholar 

  20. Meiser A, Laubenthal H (2005) Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol 19: 523–38

    Article  CAS  PubMed  Google Scholar 

  21. Berton J, Sargentini C, Nguyen JL et al. (2007) AnaConDa reflection filter: bench and patient evaluation of safety and volatile anesthetic conservation. Anesth Analg 104: 130–4

    Article  PubMed  Google Scholar 

  22. Bolon M, Boulieu R, Flamens C et al. (2002) Sédation par le midazolam en réanimation: aspects pharmacologiques et pharmacocinetiques. Ann Fr Anesth Réanim 21:n478–92

    Google Scholar 

  23. Kam PC, Cardone D (2007) Propofol infusion syndrome. Anaesthesia 62: 690–701

    Article  CAS  PubMed  Google Scholar 

  24. Bray RJ (1998) Propofol infusion syndrome in children. Paediatr Anaesth 8: 491–9

    Article  CAS  PubMed  Google Scholar 

  25. Vasile B, Rasulo F, Candiani A, Latronico N (2003) The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 29: 1417–25

    Article  PubMed  Google Scholar 

  26. Wysowski DK, Pollock ML (2006) Reports of death with use of propofol (Diprivan) for nonprocedural (long-term) sedation and literature review. Anesthesiology 105: 1047–51

    Article  PubMed  Google Scholar 

  27. Culp KE, Augoustides JG, Ochroch AE, Milas BL (2004) Clinical management of cardiogenic shock associated with prolonged propofol infusion. Anesth Analg 99: 221–6

    Article  PubMed  Google Scholar 

  28. Uezono S, Hotta Y, Takakuwa Y, Ozaki M (2005) Acquired carnitine deficiency: a clinical model for propofol infusion syndrome? Anesthesiology 103: 909

    Article  PubMed  Google Scholar 

  29. Gottardis M, Khunl-Brady KS, Koller W et al. (1989) Effect of prolonged sedation with propofol on serum triglyceride and cholesterol concentrations. Br J Anaesth 62: 393–6

    Article  CAS  PubMed  Google Scholar 

  30. McLeod G, Dick J, Wallis C et al. (1997) Propofol 2% in critically ill patients: effect on lipids. Crit Care Med 25: 1976–81

    Article  CAS  PubMed  Google Scholar 

  31. Barrientos-Vega R, Mar Sanchez-Soria M, Morales-Garcia C et al. (1997) Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 25: 33–40

    Article  CAS  PubMed  Google Scholar 

  32. Eddleston JM, Shelly MP (1991) The effect on serum lipid concentrations of a prolonged infusion of propofol-hypertriglyceridaemia associated with propofol administration. Intensive Care Med 17: 424–6

    Article  CAS  PubMed  Google Scholar 

  33. Fulton B, Sorkin EM (1995) Propofol. An overview of its pharmacology and a review of its clinical effcacy in intensive care sedation. Drugs 50: 636–57

    Article  CAS  PubMed  Google Scholar 

  34. Theilen HJ, Adam S, Albrecht MD, Ragaller M (2002) Propofol in a medium-and longchain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg 95: 923–9

    Article  CAS  PubMed  Google Scholar 

  35. Mateu J, Barrachina F (1996) Hypertriglyceridaemia associated with propofol sedation in critically ill patients. Intensive Care Med 22: 834–5

    Article  CAS  PubMed  Google Scholar 

  36. Possidente CJ, Rogers FB, Osler TM, Smith TA (1998) Elevated pancreatic enzymes after extended propofol therapy. Pharmacotherapy 18: 653–5

    CAS  PubMed  Google Scholar 

  37. Kumar AN, Schwartz DE, Lim KG (1999) Propofol-induced pancreatitis: recurrence of pancreatitis after rechallenge. Chest 115: 1198–9

    Article  CAS  PubMed  Google Scholar 

  38. Bairaktari A, Raitsiou B, Kokolaki M et al. (2001) Respiratory failure after pneumonectomy in a patient with unknown hyperlipidemia. Anesth Analg 93: 292–3

    Article  CAS  PubMed  Google Scholar 

  39. Barrientos-Vega R, Sanchez-Soria MM, Morales-Garcia C et al. (2001) Pharmacoeconomic assessment of propofol 2% used for prolonged sedation. Crit Care Med 29: 317–22

    Article  CAS  PubMed  Google Scholar 

  40. Sandiumenge Camps A, Sanchez-Izquierdo Riera JA, Toral Vazquez D et al. (2000) Midazolam and 2% propofol in long-term sedation of traumatized critically ill patients: efficacy and safety comparison. Crit Care Med 28: 3612–9

    Article  CAS  PubMed  Google Scholar 

  41. Sneyd JR (2004) Recent advances in intravenous anaesthesia. Br J Anaesth 93: 725–36

    Article  CAS  PubMed  Google Scholar 

  42. Bach A, Geiss HK (1995) Propofol and postoperative infections. N Engl J Med 333: 1505–6

    CAS  PubMed  Google Scholar 

  43. Truog RD, Cist AF, Brackett SE et al. (2001) Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care Medicine. Crit Care Med 29: 2332–48

    Article  CAS  PubMed  Google Scholar 

  44. Bennett SN, McNeil MM, Bland LA et al. (1995) Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med 333: 147–54

    Article  CAS  PubMed  Google Scholar 

  45. Abraham E, Papadakos PJ, Tharratt RS et al. (2000) Effects of propofol containing EDTA on mineral metabolism in medical ICU patients with pulmonary dysfunction. Intensive Care Med 26 Suppl 4: S422–32

    Article  PubMed  Google Scholar 

  46. Herr DL, Kelly K, Hall JB et al. (2000) Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients. Intensive Care Med 26 Suppl 4: S452–62

    Article  PubMed  Google Scholar 

  47. Barr J, Zaloga GP, Haupt MT et al. (2000) Cation metabolism during propofol sedation with and without EDTA in patients with impaired renal function. Intensive Care Med 26 Suppl 4: S433–42

    Article  PubMed  Google Scholar 

  48. Hart B (2000) ‘Diprivan’: a change of formulation. Eur J Anaesthesiol 17: 71–3

    CAS  PubMed  Google Scholar 

  49. Ma D, Sapsed-Byrne SM, Chakrabarti MK, Whitwam JG (1998) Synergistic interaction between the effects of propofol and midazolam with fentanyl on phrenic nerve activity in rabbits. Acta Anaesthesiol Scand 42: 670–7

    Article  CAS  PubMed  Google Scholar 

  50. Bouillon TW, Bruhn J, Radulescu L et al. (2004) Pharmacodynamic interaction between propofol and remifentanil regarding hypnosis, tolerance of laryngoscopy, bispectral index, and electroencephalographic approximate entropy. Anesthesiology 100: 1353–72

    Article  CAS  PubMed  Google Scholar 

  51. Battershill AJ, Keating GM (2006) Remifentanil. A review of its analgesic and sedative use in the intensive care unit. CNS Drugs 66: 365–85

    CAS  Google Scholar 

  52. Breen D, Wilmer A, Bodenham A et al. (2004) Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment. Crit Care 8: R21–30

    Article  PubMed  Google Scholar 

  53. Pitsiu M, Wilmer A, Bodenham A et al. (2004) Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment. Br J Anaesth 92: 493–503

    Article  CAS  PubMed  Google Scholar 

  54. Minto CF, Schnider TW, Egan TD et al. (1997) Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 86: 10–23

    Article  CAS  PubMed  Google Scholar 

  55. Gepts E, Shafer SL, Camu F et al. (1995) Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 83: 1194–204

    Article  CAS  PubMed  Google Scholar 

  56. Scott JC, Stanski DR (1997) Decreased fentanyl and alfentanil dose requirements with age. A simultaneous pharmacokinetic and pharmacodynamic evaluation. J Pharmacol Exp Ther 240: 159–66

    Google Scholar 

  57. Shafer SL, Varvel JR, N A, Scott JC (1990) Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 73: 1091–102

    Article  CAS  PubMed  Google Scholar 

  58. Shafer SL, Varvel JR (1991) Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 74: 53–63

    Article  CAS  PubMed  Google Scholar 

  59. Bourgoin A, Albanese J, Leone M et al. (2005) Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Crit Care Med 33: 1109–13

    Article  CAS  PubMed  Google Scholar 

  60. Muellejans B, Lopez A, Cross MH et al. (2004) Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, doubleblind controlled trial. Crit Care 8: R1–R11

    Article  PubMed  Google Scholar 

  61. Karabinis A, Mandragos K, Stergiopoulos S et al. (2004) Safety and efficacy of analgesiabased sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial. Crit Care 8: R268–80

    Article  PubMed  Google Scholar 

  62. Breen D, Karabinis A, Malbrain M et al. (2005) Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnoticbased sedation for up to 10 days in intensive care unit patients: a randomised trial. Crit Care 9: R200–10

    Article  PubMed  Google Scholar 

  63. Muellejans B, Matthey T, Scholpp J, Schill M (2006) Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial. Crit Care 10: R91

    Article  PubMed  Google Scholar 

  64. Park G, Coursin D, Ely EW et al. (2001) Balancing sedation and analgesia in the critically ill. Crit Care Clin 17: 1015–27

    Article  CAS  PubMed  Google Scholar 

  65. Park G, Lane M, Rogers S, Bassett P (2007) A comparison of hypnotic and analgesic based sedation in a general intensive care unit. Br J Anaesth 98: 76–82

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. M. Biais
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Lagneau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Sztark
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag France, Paris

About this chapter

Cite this chapter

Biais, M., Lagneau, F., Sztark, F. (2010). Pharmacologie des agents de la sédation et de l’analgésie en réanimation. In: Analgésie et sédation en réanimation. Le point sur .... Springer, Paris. https://doi.org/10.1007/978-2-287-99029-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-99029-8_5

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-99028-1

  • Online ISBN: 978-2-287-99029-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation